The Competitiveness Of The Pharmaceutical Industry In Malaysia: An Application Of Extended Porter’s Diamond Model
The Malaysian pharmaceutical manufacturing industry is facing several competitiveness issues. Among the issues are declining profitability, an increase in the number of competitors, poor export performance, limited production capacity, and a lack of innovation capabilities. Previous pharmaceutica...
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2022
|
| Subjects: | |
| Online Access: | http://eprints.usm.my/58470/1/CHONG%20HOOI%20YING%20-%20TESIS.pdf |
| _version_ | 1825907903930826752 |
|---|---|
| author | Chong, Hooi Ying |
| author_facet | Chong, Hooi Ying |
| author_sort | Chong, Hooi Ying |
| collection | USM |
| description | The Malaysian pharmaceutical manufacturing industry is facing several
competitiveness issues. Among the issues are declining profitability, an increase in the
number of competitors, poor export performance, limited production capacity, and a lack
of innovation capabilities. Previous pharmaceutical competitiveness literature
demonstrates that home country business environment factors play an important role in
determining the industry competitiveness in international trade. However, the relationship
between home country business environment factors and pharmaceutical firm
competitiveness in terms of profitability and market share remains largely unexplored.
Therefore, the purpose of this study is to investigate the influences of national business
environment factors on pharmaceutical firm competitiveness for a sample of 30
prescription medicines manufacturing firms operating in Malaysia from 2004 to 2018.
The theoretical foundation for this research is primarily derived from Porter's Diamond
Model. Static panel regression method is used to estimate the relationships between home
country business environment factors and the firm competitiveness of the Malaysian
pharmaceutical manufacturing industry. The findings suggest that country’s healthcare
expenditure per capita, capital investment efficincy, pharmaceutical exports, firm age,
and size are important in improving the firm competitiveness of Malaysia's
pharmaceutical manufacturing industry. |
| first_indexed | 2024-03-06T16:11:03Z |
| format | Thesis |
| id | usm.eprints-58470 |
| institution | Universiti Sains Malaysia |
| language | English |
| last_indexed | 2024-03-06T16:11:03Z |
| publishDate | 2022 |
| record_format | dspace |
| spelling | usm.eprints-584702023-05-11T08:02:43Z http://eprints.usm.my/58470/ The Competitiveness Of The Pharmaceutical Industry In Malaysia: An Application Of Extended Porter’s Diamond Model Chong, Hooi Ying HF5001-6182 Business HF5410-5417.5 Marketing. Distribution of products The Malaysian pharmaceutical manufacturing industry is facing several competitiveness issues. Among the issues are declining profitability, an increase in the number of competitors, poor export performance, limited production capacity, and a lack of innovation capabilities. Previous pharmaceutical competitiveness literature demonstrates that home country business environment factors play an important role in determining the industry competitiveness in international trade. However, the relationship between home country business environment factors and pharmaceutical firm competitiveness in terms of profitability and market share remains largely unexplored. Therefore, the purpose of this study is to investigate the influences of national business environment factors on pharmaceutical firm competitiveness for a sample of 30 prescription medicines manufacturing firms operating in Malaysia from 2004 to 2018. The theoretical foundation for this research is primarily derived from Porter's Diamond Model. Static panel regression method is used to estimate the relationships between home country business environment factors and the firm competitiveness of the Malaysian pharmaceutical manufacturing industry. The findings suggest that country’s healthcare expenditure per capita, capital investment efficincy, pharmaceutical exports, firm age, and size are important in improving the firm competitiveness of Malaysia's pharmaceutical manufacturing industry. 2022-01 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/58470/1/CHONG%20HOOI%20YING%20-%20TESIS.pdf Chong, Hooi Ying (2022) The Competitiveness Of The Pharmaceutical Industry In Malaysia: An Application Of Extended Porter’s Diamond Model. PhD thesis, Perpustakaan Hamzah Sendut. |
| spellingShingle | HF5001-6182 Business HF5410-5417.5 Marketing. Distribution of products Chong, Hooi Ying The Competitiveness Of The Pharmaceutical Industry In Malaysia: An Application Of Extended Porter’s Diamond Model |
| title | The Competitiveness Of The
Pharmaceutical Industry In Malaysia:
An Application Of Extended Porter’s
Diamond Model |
| title_full | The Competitiveness Of The
Pharmaceutical Industry In Malaysia:
An Application Of Extended Porter’s
Diamond Model |
| title_fullStr | The Competitiveness Of The
Pharmaceutical Industry In Malaysia:
An Application Of Extended Porter’s
Diamond Model |
| title_full_unstemmed | The Competitiveness Of The
Pharmaceutical Industry In Malaysia:
An Application Of Extended Porter’s
Diamond Model |
| title_short | The Competitiveness Of The
Pharmaceutical Industry In Malaysia:
An Application Of Extended Porter’s
Diamond Model |
| title_sort | competitiveness of the pharmaceutical industry in malaysia an application of extended porter s diamond model |
| topic | HF5001-6182 Business HF5410-5417.5 Marketing. Distribution of products |
| url | http://eprints.usm.my/58470/1/CHONG%20HOOI%20YING%20-%20TESIS.pdf |
| work_keys_str_mv | AT chonghooiying thecompetitivenessofthepharmaceuticalindustryinmalaysiaanapplicationofextendedportersdiamondmodel AT chonghooiying competitivenessofthepharmaceuticalindustryinmalaysiaanapplicationofextendedportersdiamondmodel |